A detailed history of Dnca Finance transactions in Eli Lilly & CO stock. As of the latest transaction made, Dnca Finance holds 9,413 shares of LLY stock, worth $7.43 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
9,413
Previous 20,687 54.5%
Holding current value
$7.43 Million
Previous $18.7 Billion 55.47%
% of portfolio
0.71%
Previous 1.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $8.71 Million - $10.8 Million
-11,274 Reduced 54.5%
9,413 $8.34 Billion
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $15 Million - $18.8 Million
20,687 New
20,687 $18.7 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dnca Finance Portfolio

Follow Dnca Finance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dnca Finance, based on Form 13F filings with the SEC.

News

Stay updated on Dnca Finance with notifications on news.